CYCLACEL PHARMACEUTICALS INC's ticker is CYCC and the CUSIP is 23254L603. A total of 25 filers reported holding CYCLACEL PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $10,999 | -90.3% | 275,000 | +162.6% | 0.00% | -90.5% |
Q2 2022 | $113,000 | -64.6% | 104,741 | 0.0% | 0.02% | -50.0% |
Q1 2022 | $319,000 | -17.1% | 104,741 | +5.3% | 0.04% | -26.3% |
Q4 2021 | $385,000 | -26.5% | 99,422 | 0.0% | 0.06% | +54.1% |
Q3 2021 | $524,000 | -11.6% | 99,422 | -0.6% | 0.04% | -22.9% |
Q2 2021 | $593,000 | -72.2% | 100,000 | -66.7% | 0.05% | -33.3% |
Q1 2021 | $2,133,000 | -30.2% | 300,000 | -23.4% | 0.07% | -46.7% |
Q4 2020 | $3,057,000 | – | 391,450 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SILVERARC CAPITAL MANAGEMENT, LLC | 250,000 | $1,778,000 | 0.97% |
Affinity Asset Advisors, LLC | 380,000 | $2,702,000 | 0.92% |
Tri Locum Partners LP | 293,419 | $2,086,000 | 0.52% |
SPHERA FUNDS MANAGEMENT LTD. | 508,322 | $3,614,000 | 0.28% |
J. Goldman & Co LP | 357,524 | $2,542,000 | 0.08% |
Maven Securities LTD | 250,000 | $1,787,000 | 0.08% |
Ikarian Capital, LLC | 300,000 | $2,133,000 | 0.07% |
PURA VIDA INVESTMENTS, LLC | 273,958 | $1,948,000 | 0.06% |
CVI Holdings, LLC | 59,450 | $423,000 | 0.03% |
Schonfeld Strategic Advisors LLC | 136,725 | $972,000 | 0.01% |